Search results
Japanese drugmaker Eisai's shares drop on report of death in Alzheimer's trial
Reuters via Yahoo News· 1 year agoShares in Japanese drugmaker Eisai Co fell more than 6% on Tuesday after a report that a woman who...
Eisai files for full FDA approval for Alzheimer's drug Leqembi
Reuters via Yahoo Finance· 1 year ago(Reuters) - Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the...
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected
Reuters via Yahoo News· 2 months agoJapanese drugmaker Eisai on Thursday said the distribution of its Alzheimer's drug Leqembi in the...
Eisai, Biogen say FDA grants priority review for Alzheimer's drug Lecanemab
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) - Japanese drugmaker Eisai Co Ltd and its U.S. partner Biogen Inc said on Monday...
Eisai, Biogen say Alzheimer's drug Lecanemab getting priority review in China
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) - Japanese drugmaker Eisai Co Ltd and U.S. biotech firm Biogen Inc said on Tuesday...
Experimental Alzheimer’s drug shows benefits in phase 3 trial, company says
The Today Show via AOL· 2 years agoThe Japanese drugmaker Eisai said Tuesday its experimental drug for Alzheimer’s disease helped slow...
Drug slows Alzheimer's but can it make a real difference?
Associated Press via AOL· 1 year agoJapanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug...
The first drug that slows Alzheimer's has finally received FDA approval
Engadget· 10 months agoJapanese drugmaker Eisai and US-based Biogen have received FDA approval for Leqembi, making it the...
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
AP Finance via Yahoo Finance· 7 months agoJapan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly...
Japan grants priority review status to Alzheimer's treatment from Eisai-Biogen
Reuters via Yahoo Finance· 1 year agoJan 29 (Reuters) - Japanese drugmaker Eisai Co Ltd and Biogen Inc said on Sunday the Japanese Ministry of Health, Labour and Welfare has given priority review for their Alzheimer's disease drug ...